Drug Profile
Research programme: anti-inflammatory therapeutics - onepharm
Alternative Names: OPM-3023 derivativesLatest Information Update: 03 Mar 2011
Price :
$50
*
At a glance
- Originator onepharm
- Class
- Mechanism of Action Osteoclast inhibitors; Steroid inhibitors; Virus attachment inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
- Discontinued Viral infections
Most Recent Events
- 03 Mar 2011 No development reported for Inflammation in Austria (unspecified route)
- 11 Nov 2009 Discontinued for Viral infections in Austria (unspecified route)